|
||||||
|
 | |
| |
| |
| |
| |
|
Fusion gene ID: 42939 |
FusionGeneSummary for ZMIZ1_XYLT2 |
 Fusion gene summary |
| Fusion gene information | Fusion gene name: ZMIZ1_XYLT2 | Fusion gene ID: 42939 | Hgene | Tgene | Gene symbol | ZMIZ1 | XYLT2 | Gene ID | 57178 | 64132 |
| Gene name | zinc finger MIZ-type containing 1 | xylosyltransferase 2 | |
| Synonyms | MIZ|RAI17|TRAFIP10|ZIMP10 | PXYLT2|SOS|XT-II|XT2|xylT-II | |
| Cytomap | 10q22.3 | 17q21.33 | |
| Type of gene | protein-coding | protein-coding | |
| Description | zinc finger MIZ domain-containing protein 1retinoic acid induced 17zinc finger-containing, Miz1, PIAS-like protein on chromosome 10 | xylosyltransferase 2UDP-D-xylose:proteoglycan core protein beta-D-xylosyltransferasepeptide O-xylosyltransferase 1protein xylosyltransferase 2xylosyltransferase II | |
| Modification date | 20180519 | 20180519 | |
| UniProtAcc | Q9ULJ6 | Q9H1B5 | |
| Ensembl transtripts involved in fusion gene | ENST00000334512, ENST00000478357, ENST00000446377, | ENST00000017003, ENST00000507602, | |
| Fusion gene scores | * DoF score | 14 X 8 X 8=896 | 4 X 2 X 4=32 |
| # samples | 14 | 4 | |
| ** MAII score | log2(14/896*10)=-2.67807190511264 possibly effective Gene in Pan-Cancer Fusion Genes (peGinPCFGs). DoF>8 and MAII<0 | log2(4/32*10)=0.321928094887362 effective Gene in Pan-Cancer Fusion Genes (eGinPCFGs). DoF>8 and MAII>0 | |
| Context | PubMed: ZMIZ1 [Title/Abstract] AND XYLT2 [Title/Abstract] AND fusion [Title/Abstract] | ||
| Functional or gene categories assigned by FusionGDB annotation | |||
| * DoF score (Degree of Frequency) = # partners X # break points X # cancer types ** MAII score (Major Active Isofusion Index) = log2(# samples/DoF score*10) |
| Gene ontology of each fusion partner gene with evidence of Inferred from Direct Assay (IDA) from Entrez |
| Partner | Gene | GO ID | GO term | PubMed ID |
| Hgene | ZMIZ1 | GO:0045944 | positive regulation of transcription by RNA polymerase II | 26522984 |
| Fusion gene information from three resources (ChiTars (NAR, 2018), tumorfusions (NAR, 2018), Gao et al. (Cell, 2018)) * All genome coordinats were lifted-over on hg19. * Click on the break point to see the gene structure around the break point region using the UCSC Genome Browser. |
| Data type | Source | Cancer type | Sample | Hgene | Hchr | Hbp | Hstrand | Tgene | Tchr | Tbp | Tstrand |
| TCGA | RV | SKCM | TCGA-D3-A3C7-06A | ZMIZ1 | chr10 | 80976031 | + | XYLT2 | chr17 | 48430991 | + |
| * LD: Li Ding group's fusion gene list RV: Roel Verhaak group's fusion gene list ChiTaRs fusion database |
| Open reading frame (ORF) analsis of fusion genes based on Ensembl gene isoform structure. * Click on the break point to see the gene structure around the break point region using the UCSC Genome Browser. |
| ORF | Henst | Tenst | Hgene | Hchr | Hbp | Hstrand | Tgene | Tchr | Tbp | Tstrand |
| Frame-shift | ENST00000334512 | ENST00000017003 | ZMIZ1 | chr10 | 80976031 | + | XYLT2 | chr17 | 48430991 | + |
| Frame-shift | ENST00000334512 | ENST00000507602 | ZMIZ1 | chr10 | 80976031 | + | XYLT2 | chr17 | 48430991 | + |
| intron-3CDS | ENST00000478357 | ENST00000017003 | ZMIZ1 | chr10 | 80976031 | + | XYLT2 | chr17 | 48430991 | + |
| intron-3CDS | ENST00000478357 | ENST00000507602 | ZMIZ1 | chr10 | 80976031 | + | XYLT2 | chr17 | 48430991 | + |
| intron-3CDS | ENST00000446377 | ENST00000017003 | ZMIZ1 | chr10 | 80976031 | + | XYLT2 | chr17 | 48430991 | + |
| intron-3CDS | ENST00000446377 | ENST00000507602 | ZMIZ1 | chr10 | 80976031 | + | XYLT2 | chr17 | 48430991 | + |
Top |
FusionProtFeatures for ZMIZ1_XYLT2 |
| Main function of each fusion partner protein. (from UniProt) |
| Hgene | Tgene |
| ZMIZ1 | XYLT2 |
| Acts as transcriptional coactivator. Increases ligand-dependent transcriptional activity of AR and promotes ARsumoylation. The stimulation of AR activity is dependent uponsumoylation (PubMed:14609956, PubMed:26522984). Involved intranscriptional activation of a subset of NOTCH1 target genesincluding MYC. Involved in thymocyte and T cell development (Bysimilarity). {ECO:0000250|UniProtKB:Q6P1E1,ECO:0000269|PubMed:14609956, ECO:0000269|PubMed:26522984}. | Catalyzes the first step in the biosynthesis ofchondroitin sulfate, heparan sulfate and dermatan sulfateproteoglycans, such as DCN. Transfers D-xylose from UDP-D-xyloseto specific serine residues of the core protein.{ECO:0000269|PubMed:17189265, ECO:0000269|PubMed:26027496}. |
| Retention analysis result of each fusion partner protein across 39 protein features of UniProt such as six molecule processing features, 13 region features, four site features, six amino acid modification features, two natural variation features, five experimental info features, and 3 secondary structure features. Here, because of limited space for viewing, we only show the protein feature retention information belong to the 13 regional features. All retention annotation result can be downloaded at . * Minus value of BPloci means that the break pointn is located before the CDS. |
| - In-frame and retained protein feature among the 13 regional features. |
| Partner | Gene | Hbp | Tbp | ENST | Strand | BPexon | TotalExon | Protein feature loci | *BPloci | TotalLen | Protein feature | Protein feature note |
| - In-frame and not-retained protein feature among the 13 regional features. |
| Partner | Gene | Hbp | Tbp | ENST | Strand | BPexon | TotalExon | Protein feature loci | *BPloci | TotalLen | Protein feature | Protein feature note |
Top |
FusionGeneSequence for ZMIZ1_XYLT2 |
| For in-frame fusion transcripts, we provide the fusion transcript sequences and fusion amino acid sequences. (nt: nucleotides, aa: amino acids) |
| * Fusion amino acid sequences. |
| * Fusion transcript sequences (only coding sequence (CDS) region). |
| * Fusion transcript sequences (Full-length transcript). |
Top |
FusionGenePPI for ZMIZ1_XYLT2 |
| Go to ChiPPI (Chimeric Protein-Protein interactions) to see the chimeric PPI interaction in . |
| Protein-protein interactors with each fusion partner protein in wild-type (BIOGRID-3.4.160) |
| Hgene | Hgene's interactors | Tgene | Tgene's interactors |
| ZMIZ1 | AR, TP53, PIAS3, CNTNAP2, SMAD3, SMAD4, SETD4, NANOG, MAML1, RBPJ, NOTCH1, TRIM28, SATB1, NFATC3, CTNNB1, ZEB1, CCR7, BRCA1, BCLAF1, TCF7, SIRT1, ETS1, TRIM25 | XYLT2 | TAZ, IDS, POMK, CAMK1D, B4GALT3, FAM134C, GPC1, UST, CLEC2D, SCGB2A2, LYPD4, LPAR1, RFX3, HDAC1, RTCB, MTA2, PTOV1, TBC1D32, DDX1, RFX1, CDK20, TAF6L, FOXJ1 |
| - Retained PPIs in in-frame fusion. |
| Partner | Gene | Hbp | Tbp | ENST | Strand | BPexon | TotalExon | Protein feature loci | *BPloci | TotalLen | Still interaction with |
| - Lost PPIs in in-frame fusion. |
| Partner | Gene | Hbp | Tbp | ENST | Strand | BPexon | TotalExon | Protein feature loci | *BPloci | TotalLen | Interaction lost with |
| - Retained PPIs, but lost function due to frame-shift fusion. |
| Partner | Gene | Hbp | Tbp | ENST | Strand | BPexon | TotalExon | Protein feature loci | *BPloci | TotalLen | Interaction lost with |
Top |
RelatedDrugs for ZMIZ1_XYLT2 |
| Drugs targeting genes involved in this fusion gene. (DrugBank Version 5.1.0 2018-04-02) |
| Partner | Gene | UniProtAcc | DrugBank ID | Drug name | Drug activity | Drug type | Drug status |
Top |
RelatedDiseases for ZMIZ1_XYLT2 |
| Diseases associated with fusion partners. (DisGeNet 4.0) |
| Partner | Gene | Disease ID | Disease name | # pubmeds | Source |
| Hgene | ZMIZ1 | C0007570 | Celiac Disease | 1 | CTD_human |
| Hgene | ZMIZ1 | C0009404 | Colorectal Neoplasms | 1 | CTD_human |
| Tgene | XYLT2 | C0033847 | Pseudoxanthoma Elasticum | 1 | CTD_human;UNIPROT |
Copyright 2018-Present -The University of Texas Health Science Center at Houston (UTHealth)
|